Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profiling of Dermal Papilla (DP) cells isolated from wild type (WT) and DP-specific Smo gain-of-function (Smo*) mutant mice during both telogen (at P20) and anagen (at P28).

ABSTRACT: Gene expression analysis revealed that the DP transcriptome is altered in the Smo* mutant. At P28 the expression of 2226 genes was significantly altered. The expression of 473 genes was altered in the Smo* mutant during telogen (P20).

ORGANISM(S): Mus musculus

PROVIDER: GSE115649 | GEO | 2019/06/12

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Gene expression profiling of Dermal Papilla (DP) cells isolated from wild type (WT) and DP-specific Smo gain-of-function (Smo*) mutant mice during both telogen (at P20) and anagen (at P28).

Project description:Gene expression profiling of Dermal Papilla (DP) cells isolated from wild type (WT) and DP-specific Smo gain-of-function (Smo*) mutant mice during both telogen (at P20) and anagen (at P28).

| PRJNA475677 | ENA

Clostridioides difficile P28

Project description:Clostridioides difficile P28 Genome sequencing and assembly

| PRJNA85995 | ENA

RNA sequencing of Foxd1Cre;Smo(flox/-) mutant kidneys

Project description:Purpose: To analyze the mRNA content of Foxd1Cre;Smo(flox/-) mutant kidneys. Methods: We collected E13.5 wildtype and Foxd1Cre;Smo(flox/-) mutant kidneys and isolated RNA to do RNA-Seq. Results: Identified differentially expressed transcripts in Foxd1Cre;Smo(flox/-) mutant kidneys compared to wildtype controls. Conclusions: Our work provides novel insight into how Hedgehog signaling from stromal cells influences renal development.

2018-06-26 | GSE103923 | GEO

Exogenous R-Spondin1 Induces Precocious Telogen-to-Anagen Transition in Mouse Hair Follicles.

Project description: Not available

| S-EPMC4849038 | biostudies-literature

Dmrt1 (doublesex and mab-3 related transcription factor 1) conditional knockout expression analysis of P28 testes

Project description:Dmrt1 (doublesex and mab-3 related transcription factor 1) is a conserved transcriptional regulator of male differentiation required for testicular development in vertebrates. This study examines the result of conditional removal of Dmrt1 from Sertoli cells in P28 testis tissue. Testes from P28 Dmrt1 flox/flox mice were compared to testes from P28 Dmrt1 flox/flox mice with the Sertoli cell-specific Sf1 (Nr5a1; MGI:1346833) or Dhh (MGI:94891) promoters driving Cre expression.

2011-07-28 | E-GEOD-27261 | biostudies-arrayexpress

The balance of Bmp6 and Wnt10b regulates the telogen-anagen transition of hair follicles.

Project description: Not available

| S-EPMC6385416 | biostudies-literature

SMO variants explain the majority of drug resistance in basal cell carcinoma [Target Sequencing]

Project description:Advanced basal cell carcinomas (BCCs) frequently acquire resistance to Smoothened (SMO) inhibitors through unknown mechanisms, providing a unique opportunity to study human tumor evolution. Here, we identify SMO mutations in 50% (22/44) of resistant BCCs compared with 5.6% (2/36) of untreated BCCs (p<0.0001), and show that these mutations maintain Hedgehog signaling in the presence of SMO inhibitors. Alterations include four ligand binding pocket (LBP) mutations that define sites of inhibitor binding and four variants that confer constitutive activity and inhibitor resistance, thus defining pivotal residues of SMO that ensure receptor autoinhibition. Finally, we show that both classes of SMO variants respond to the aPKC-ι/λ inhibitor PSI and GLI2 antagonist ATO that operate downstream of SMO

2015-03-16 | GSE58376 | GEO

SMO variants explain the majority of drug resistance in basal cell carcinoma [RNA-Seq]

2015-03-16 | GSE58375 | GEO

SMO variants explain the majority of drug resistance in basal cell carcinoma [exome-seq]

2015-03-16 | GSE58374 | GEO

GBM response to Smo and PI3K inhibitors

Project description:Combination therapy with Smo and PI3K inhibitors results in a synergistic effect in reducing tumor growth in PTEN-deficient Glioblastoma. To identify consequences of combination therapy with an Smo inhibitor and a PI3K inhibitor on a genome-wide scale, we performed Affymetrix microarrays with two different PTEN-deficient GBMs treated with single drugs or combination therapy. A small set of genes was significantly affected by combination therapy in hBT70 and/or hBT112, including several genes implicated in GBM prognosis, or identified as targets of Shh, PI3K or S6 pathways 29-33 .

2013-09-01 | GSE49416 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data